September 10, 2024 IntegriChain and Federal Compliance Solutions Experts to Speak on the Intricacies Inflation Reduction Act at MDRP Summit Two IntegriChain pharmaceutical pricing and regulatory experts will speak at the Medicaid Drug Rebate Reporting Summit 2024, September 23 to 25 in Chicago, IL.
September 5, 2024 IntegriChain’s Access Insights Conference to Feature Powerhouse Roster of Pharma Industry Thought Leaders IntegriChain announces the growing roster of Pharma industry thought leaders speaking at its annual Access Insights Conference. The conference, co-hosted with Blue Fin Group and Federal Compliance Solutions, will be held October 14-16, 2024, at The Mayflower Hotel, Autograph Collection, in Washington, DC.
September 3, 2024 IntegriChain Appoints Tim Murdoch as Chief Commercial Officer to Drive Continued Growth and Customer Value IntegriChain appoints Tim Murdock – a seasoned enterprise technology sales and marketing executive with more than 20 years of experience at SaaS leaders such as Adobe, Salesforce, and SAP – as Chief Commercial Officer.
August 20, 2024 IntegriChain Appoints Experienced High-Growth Finance Executive as CFO IntegriChain appoints Matt Heyman as Chief Financial Officer. Heyman brings IntegriChain more than a decade of experience in corporate finance, strategy, and M&A, predominately within public and private software businesses.
July 9, 2024 IntegriChain Acquires Federal Compliance Solutions, Creating Pharma’s Deepest Contracts & Pricing and Gross-to-Net Advisory and Outsourcing Team IntegriChain has acquired Federal Compliance Solutions (FCS), a leading Pharma advisory and managed services firm. This transaction creates the industry’s deepest team of experts in government pricing and payer/provider contracting, areas that have simultaneously become more outsourced in Pharma and the focus of significant regulatory and commercial changes. The combination builds on the technology, people, and pr
June 18, 2024 IntegriChain Acquires BridgeView Data Solutions, Creating the Pharmaceutical Industry’s Best-in-Class Commercial Data Solution IntegriChain has acquired BridgeView Data Solutions, the commercial data warehouse and data aggregation assets of BridgeView Life Sciences LLC (formerly Coeus Solutions) – together delivering best-in-class first- and third-party data aggregation, AI-assisted data exploration capabilities, field intelligence and alerting, and commercial data warehouse (CDW) offerings.
May 14, 2024 IntegriChain Expert to Speak on Best Price Stacking Impacts at Informa Pricing and Contracting USA Jeff Baab, Vice President of Advisory Services, will speak at Informa’s Pricing and Contracting USA conference. The session will focus on forecasting impacts of best price stacking. The hybrid conference runs May 21-23 in New Orleans, Louisiana.
April 9, 2024 Registration Opens for Access Insights Conference 2024 Co-Hosted by IntegriChain and Blue Fin Group Registration is open for the Access Insights Conference 2024, October 14-16 in Washington, DC, and co-hosted with Blue Fin Group. Designed for commercial, operational, and financial teams at pharma manufacturers, the conference will feature industry panels, healthcare policy and financial experts, and strategic and tactical best practices for data-driven patient access and therapy commercialization.
February 28, 2024 Longtime Gilead Commercial Executive Joins IntegriChain as Chairman of the Board IntegriChain appoints Jim Meyers, a highly experienced pharmaceutical commercialization executive, as Chairman of the Board. Meyers offers more than 35 years of industry experience, from his more than two decades at Gilead Sciences where he served as Chief Commercial Officer and EVP of Worldwide Commercial Operations to his leadership in emerging biopharma as a board member for a broad spectrum of clinical-stage companies.
